Sönnerstam Eva, Harlin Frida, Gustafsson Maria
Department of Integrative Medical Biology, Umeå University, SE-901 87, Umeå, Sweden.
Department of Integrative Medical Biology, Umeå University, SE-901 87, Umeå, Sweden.
Res Social Adm Pharm. 2023 May;19(5):758-763. doi: 10.1016/j.sapharm.2023.01.010. Epub 2023 Jan 26.
The use of potentially inappropriate medications (PIMs) is a problem since it might contribute significantly to adverse drug reactions and hospital admissions among elderly with major neurocognitive disorder (NCD). To assess the appropriateness of drug treatment, different explicit criteria have been developed.
To investigate and compare the prevalence of PIM users among elderly with major NCD on a nationwide basis using 3 different explicit criteria. Furthermore, the study aimed to investigate factors associated with the use of PIMs.
This nationwide register-based study included 35,212 people, 65 years or older, diagnosed with major NCD and registered in the Swedish registry for cognitive/dementia disorders up to June 30, 2017 and alive December 31, 2017. PIMs were identified using 3 different explicit criteria; the Swedish quality indicators, the EU(7)-PIM list and the AGS Beers Criteria. PIM use was defined as having collected a minimum of one PIM at least once between July 01 - December 31, 2017.
The numbers of people using one or more PIMs were 7629 (21.7%) according to the Swedish quality indicators, 11,838 (33.6%) according to the EU(7)-PIM list, and 12,002 (34.1%) according to AGS Beers Criteria. Antipsychotics, antithrombotic agents and anxiolytics were the most frequently used PIM class according to the different assessment tools, respectively. The use of PIMs was positively associated with vascular dementia and Lewy body dementia/Parkinson's disease dementia, regardless of the assessment tool used. However, the association between using at least one PIM and age, sex, MMT-value and frontotemporal dementia, differed depending on the criteria used.
The different results and included PIMs indicate the different perspectives on PIMs between criteria, which make it difficult to compare the results. However, psychotropic drug use requires further highlighting, as well as the association between PIM use and different types of major NCD.
使用潜在不适当药物(PIMs)是一个问题,因为它可能会显著导致患有重度神经认知障碍(NCD)的老年人出现药物不良反应和住院。为了评估药物治疗的适当性,已制定了不同的明确标准。
使用3种不同的明确标准,在全国范围内调查和比较患有重度NCD的老年人中PIM使用者的患病率。此外,该研究旨在调查与使用PIMs相关的因素。
这项基于全国登记册的研究纳入了35212名65岁及以上的人,他们被诊断患有重度NCD,并在瑞典认知/痴呆症登记册中登记,截至2017年6月30日,且在2017年(2017年12月31日)仍在世。使用3种不同的明确标准识别PIMs;瑞典质量指标、欧盟(7)-PIM清单和美国老年医学会(AGS)Beers标准。PIM使用被定义为在2017年7月1日至12月31日期间至少收集到一种PIM至少一次。
根据瑞典质量指标,使用一种或多种PIM的人数为7629人(21.7%),根据欧盟(7)-PIM清单为11838人(33.6%),根据美国老年医学会(AGS)Beers标准为12002人(34.1%)。根据不同的评估工具,抗精神病药、抗血栓药和抗焦虑药分别是最常使用的PIM类别。无论使用何种评估工具,PIM的使用与血管性痴呆和路易体痴呆/帕金森病痴呆呈正相关。然而,使用至少一种PIM与年龄、性别、简易精神状态检查表(MMT)值和额颞叶痴呆之间的关联,因所使用的标准而异。
不同的结果和所包含的PIM表明了不同标准之间对PIM的不同观点,这使得结果难以比较。然而,精神药物的使用需要进一步强调,以及PIM使用与不同类型的重度NCD之间的关联。